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Abstract. The teratocarcinoma-derived C1 clone be- 
haves as a mesodermal tripotential progenitor cell 
whose choice of fate, either osteoblast, chondroblast, or 
adipoblast, is strictly dependent on the spatial organiza- 
tion of the cells and the nature of the induction. In the 
absence of cell contact before the addition of inducers, 
the C1 cells maintain a stable undifferentiated pheno- 
type while expressing potential regulators of embryonic 
mesodermal stem cell fate such a M-twist and Idl. Upon 
establishment of cell contacts before the induction of 
differentiation, the early genes characteristic of the 
three fates become expressed. In the presence of [3 glyc- 
erophosphate and ascorbate, provided the cells have 
formed aggregates, 95% of the C1 cells mineralize with 
a kinetics of gene expression close to that of osteoblasts 
(Poliard, A., D. Lamblin, P. J. Marie, M. H. Buc, and O. 
Kellermann. 1993. J. Cell Sci. 106:503-512). With 
10-6M dexamethasone, 80% of the same aggregates 
differentiate into loci of chondroblast-like cells. The ki- 
netics of expression of the genes encoding type II, IX, 
X, and XI collagens, aggrecan and link protein during 
the conversion towards cartilage hypertrophy resem- 
bles that accompanying in vivo chondrogenesis. The 
synergistic action of dexamethasone and insulin con- 
vert most confluent C1 cells into functional adipocytes 
and induce a pattern of gene expression close to that re- 
ported for adipoblast cell lines. The C1 clone with its 
capacity to differentiate along three alternative path- 
ways with high frequency, therefore appears as a valid 
in vitro model for deciphering the molecular basis of 
mesoblast ontogeny. 
T 
HE molecular and cellular mechanisms  underlying 
the  sequential differentiation of mesodermal cells 
have been the object of numerous studies. For this 
purpose, cell culture models containing presumptive pro- 
genitors capable of giving rise to different mesodermal cell 
types have been established from embryonic tissues (Ko- 
nieczny and Emerson, 1984; Grigoriadis et al.,  1988; Tay- 
lor  and  Jones,  1979),  bone  or  muscle  primary  cultures 
(Yamaguchi and Kahn,  1991; Jakob et al.,  1978), mouse 
teratocarcinoma (Darmon et al., 1984; Atsumi et al., 1990), 
or bone marrow stroma (Bennett et al., 1991; Beresford, 
1989; Fridenstein, 1976). In such cultures, subsets  of the 
same cell line often concurrently express several pheno- 
types  and  may spontaneously favor a  single  phenotype. 
Such behavior has allowed one to follow the development 
of myogenic, chondrogenic, adipogenic, or osteogenic col- 
ony-forming ceils.  However, the  mesodermal progenitor 
cell itself, which presumably gives rise to all of these lin- 
eages, has not yet been identified. 
The clonal frequency of conversion of the pluripotential 
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cells towards one phenotype always appears less than 40%, 
even under culture conditions favoring one restricted lin- 
eage (Taylor and Jones, 1979; Darmon et al., 1984; Grigo- 
riadis et al., 1988; Bennett et al.,  1991).  For example, the 
mouse embryonic cell line C3H10T1/2, which has proven 
to be a powerful in vitro model for isolation of myogenic 
determination factors does not  escape  this  behavior.  In 
this cell line, 5-azacytidine treatment mediates a stable, in- 
heritable change through an irreversible DNA hypometh- 
ylation which  activates one of the  three regulatory pro- 
grams leading to myofibers, chondrocytes, or adipocytes. 
Incorporation of 5-azacytidine into the DNA molecule is 
sufficient to convert 30-40% of the parental 10T1/2 cells; 
25%  becoming myofibers, 7% adipocytes, and 1% chon- 
drocytes-like cells (Taylor and Jones, 1979; Konieczny and 
Emerson,  1984). It has been proposed that the parental 
10T1/2 cells behave as pluripotential cells blocked in the 
mesodermal developmental pathway. Such a block is over- 
come by a  direct action on DNA, mediated by indepen- 
dent demethylation events. This action is  sufficient to di- 
rectly convert the  stem  cell into three progenitors each 
determined towards one of the three lineages. Recently, 
bone morphogenetic protein-2, one of the signaling mole- 
cules taking  part  into  the  initiation  of embryonic bone 
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be  also  capable  to  induce  the  codifferentiation  of  the 
C3H10T1/2 cells into fat, cartilage, and bone (Wang et al., 
1993b; Ahrens et al., 1993).  But the frequency of differen- 
tiation towards one particular phenotype remains low par- 
ticularly in the case of cartilage. Therefore mutually exclu- 
sive and homogenous differentiation pathways in response 
to changing signals have never been obtained for a clonal 
mesodermal progenitor cell. 
One method of choice to unravel some of the complex- 
ity of cell type determination and to evaluate the nature of 
external  influences  capable  of triggering  the  alternative 
decisions of a mesodermal stem cell, would be to isolate an 
immortalized cell line which is stable in a  stem cell state 
and capable of further homogeneous differentiation after 
in vitro appropriate induction.  We previously reported a 
successful strategy for immortalizing precursor cells from 
an embryonal carcinoma cell line (EC) 1 with the help of a 
recombinant plasmid  PK4  containing  the  early genes  of 
SV40 under the control of the adenovirus E1A promoter 
(Kellermann  and  Kelly,  1986;  Kellermann  et  al.,  1987). 
This promoter allows the expression of SV40 oncogenes in 
early embryonic cells  at the  very time differentiation  of 
multipotential EC cells is induced and, consequently, pro- 
motes the immortalization of committed precursors along 
neuroectodermal, endodermal, and mesodermal pathways 
(Kellermann et al.,  1987;  Buc-Caron et al.,  1990;  Keller- 
mann et al., 1990). Our idea was that such an immortalization 
step could freeze a progenitor cell in a particular determi- 
nation state, thereby providing a source of homogeneous 
clonal stem cells capable of further differentiating towards 
different fates upon induction by appropriate stimuli. 
Among the EC cell lines that we could transform, one of 
them,  1003-PK4,  enabled  us to select the  C1  clone.  The 
method of cloning of the C1 cell by limiting dilution from 
an island of cells resembling the somitic embryonic meso- 
derm has been described (Kellermann et al., 1990). This is- 
land was mainly composed of mesoblastic cells able to dif- 
ferentiate into either myogenic, fibrogenic, adipogenic, or 
osteogenic derivatives. The  mesodermal clone  C1  never 
spontaneously differentiates in vitro. The osteogenic po- 
tential of C1 was first established in vivo by the production 
of osteosarcoma. In vitro, when cultured in three dimen- 
sional (3D) aggregates, C1 cells were shown to engage in a 
synchronous manner through the well-characterized steps 
of osteogenic differentiation upon addition of both ascor- 
bic acid  (AA)  and  [3-glycerophosphate  ([3GP).  Remark- 
ably, under such conditions, more than 95 %  of the aggre- 
gates  secrete  a  type  I  Col  extracellular  matrix  which 
progressively mineralizes. The kinetics of osteogenic dif- 
ferentiation  has  already  been  well  characterized  at  the 
level of both the histology of the mineralizing aggregates 
and the expression of a set of genes representative of bone 
matrix proteins (Kellermann et al., 1990; Chentoufi et al., 
1993;  Poliard  et  al.,  1993).  Under  AA and  [3GP  culture 
conditions, C1 cells appear univocally committed towards 
1. Abbreviations  used in this paper: 3D, three dimensional; AA, ascorbic 
acid: A2COL6, a2 chain of type VI Collagen; ALBP, adipocyte lipid-bind- 
ing protein;  13GP, 13-glycerophosphate; Col, collagen; DEX, dexametha- 
sone;  EC,  embryonal  carcinoma  cells;  GAPDH,  glyceraldehyde phos- 
phate dehydrogenase; GPDH, glycerol-3-phosphate dehydrogenase; LPL, 
lipoprotein lipase. 
the osteogenic pathway, the lack of a type II collagen ma- 
trix detection further indicating the total absence of carti- 
lage formation in the aggregates. 
In the present study, we show that the C1 cells can also 
follow two other pathways  of differentiation,  giving rise 
under  the  action  of the  appropriate  inducers  to  either 
chondroblast-like or adipocyte-like cells. The high frequency 
of differentiation of C1 precursor cells allow us to follow 
the gene expression pattern accompanying the transition 
towards  the  terminal  phases  of chondrogenic  or  adipo- 
genic differentiation. 
In conclusion, the C1 clone has the properties of a tripo- 
tential mesodermal progenitor cell having the capacity of 
both multiply in a stable manner and produce a progeny 
whose choice of fate is driven by the nature of extracellu- 
lar signals. 
Materials and Methods 
Cell Culture and Differentiation 
C1 cells were cultured as described (Kellermann et al., 1990). To form 3D 
aggregates, C1 cells were seeded at 3 ×  105 cells per 10 ml of DME supple- 
mented with 10% FCS on untreated plastic dishes. After 9 d (day 0), the 
3D clusters (4,000-5,000 per dish) were refed with DME supplemented 
with 1% FCS and induced to differentiate (a) along the osteogenic path- 
way by the addition of 50 ~g/ml AA and 7 mM ~GP, or (b)  along the 
chondrogenic pathway by the addition of 10  6M dexamethasone (DEX). 
To induce adipocyte differentiation, C1 cells were grown to confluence in 
DME supplemented with 10% FCS and further treated by 10-7M DEX 
and 10-6M insulin in DME supplemented with 1% FCS. Cells were refed 
every 3 d with or without pharmacological effectors. Exponential cultures 
were established by dissociating confluent cells, and seeding them at low 
density (5 ×  102 cells per cm  2) without cell-cell contacts during 3 d. 
DNA Probes 
The following DNA probes were used: mouse type I and type II collagen 
(Col)  cDNA  EcoRI-HindIII  inserts  of  321  and  405  bp,  respectively 
(Mets~iranta et al., 1991);  mouse type X Col cDNA HindIII insert of 360 
bp (Apte et al., 1992); rat aggrecan cDNA Pstl insert of 710 bp (Doege et 
al., 1987);  rat link protein cDNA EcoRI insert of 820 bp (Doege et al., 
1986; Rhodes et al., 1988); mouse type XI Col cDNA XbaI-XhoI insert of 
800 bp (Stubbs et al., 1993);  rat osteocalcin (OC) cDNA EcoRI insert of 
520 bp (Yoon et al., 1988); Xenopns boralis histone H4 genomic HindIII- 
XbaI fragment of 594 bp; rat glyceraldehyde phosphate dehydrogenase 
(GAPDH) cDNA PstI insert of 1.3 kb (Fort et al., 1985); a probe for type 
IX Col corresponding to a cDNA EcoRI insert of 1 kb; mouse c~2-chain of 
type VI Col (A2COL6) cDNA EcoR1 insert of 2.9 kb (Dani et al., 1989); 
mouse lipoprotein lipase (LPL) cDNA EcoRI insert of 1.4 kb (Kirchgess- 
ner et al., 1987);  mouse adipocyte lipid-binding protein (ALBP) cDNA 
pST1 insert of 600 bp (Spiegelman et al., 1983);  mouse glycerol-3-phos- 
phate dehydrogenase (GPDH) HindIII gene fragment of 0.8 kb (Ireland 
et al., 1986);  mouse Twist cDNA XbaI-EcoRI insert of 420 bp (Wolf et 
al., 1991); and Id cDNA SmaI insert of 920 bp (Benezra et al., 1990). 
RNA Isolation and Northern Blot Analyses 
Total RNA was isolated and Northern blot analyses were performed as de- 
scribed (Pollard et al., 1993). Poly A ÷ RNA was prepared with the mRNA 
Purification Kit (Pharmacia Biotechnology, Piscataway, NJ). 
Histochemical, In Situ, Immunocytochemical, 
and Electron Microscopy Studies 
For histochemical analyses, the formed nodules were fixed in 90% ethanol 
at 4°C and embedded in glycolmethacrylate. 5-p~m sections were stained 
with toluidine blue. Immunocytochemical analyses and in situ hybridiza- 
tion studies of C1 cell aggregates were performed as described (Poliard et 
al., 1993).  Aggregate sections were treated for 1 h with 0.3 U/ml of chon- 
droitinase ABC (Boehringer Mannheim Corp., Indianapolis, IN) in 0.1 M 
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95%  was then performed. Indirect immunofluorescence was carried out 
using as primary antibodies (a) a rabbit anti-mouse type I Col polyclonal 
antiserum (Chemicon International  Inc., Temecula,  CA);  (b)  a  mono- 
clonal anti-chicken type II Col (Mayne et al., 1994); (c) a specific mono- 
clonal antibody against cartilage proteoglycan (Miles, Bayer Diagnostics); 
(d) a goat anti-mouse osteocalcin antibody (BTI, Stoughton, MA). Spe- 
cific secondary antisera coupled to fluorescein were used to visualize the 
sites of primary antibody binding. Electron microscopy was performed as 
described (Kellermann et al., 1990). 
Lipolysis Assays 
Lipolysis experiments were carried out as described (Forest et al., 1983). 
Cells were induced to differentiate in 35-mm tissue culture dishes. After 
17  d,  lipid  labeling  was  performed  during  48  h  by  adding  0.5  ~tCie 
1-[14C]acetate  (ICN, 40-60 mCi/mmol) in 2.5 ml DME supplemented by 
1% FCS, 10-7M DEX, and 10-6M insulin. The labeling procedure was re- 
peated once. For lipolysis assays, cells were rinsed twice at 37°C with PBS, 
and then incubated in 2 ml DEM containing 1% bovine serum albumin 
(Sigma; fatty acid-free). Radioactivity present in the medium was mea- 
sured 30 min later (time 0) and the effectors were added. Samples of the 
medium were checked for the presence of fatty acid-linked radioactivity 1 
and 2 h later. 
Results 
Specific Phenotypic Conversion of C1 Mesodermal 
Cells into Osteocyte-, Chondrocyte-,  or Adipocyte-like 
Cells Depends on Distinct Epigenetic  Conditions 
In vivo embryonic skeleton formation depends  critically 
on  the  condensation  of mesodermal stem cells.  Accord- 
ingly, C1 cells were cultured in 3D aggregates to search for 
the  induction  of  either  osteogenic  or  chrondrogenic  in 
vitro differentiation.  As already reported, when cultured 
as nodules in the presence of AA and t3GP, C1 cells de- 
posit a type I collagenous extracellular matrix which pro- 
gressively mineralizes (Fig. 1 B) and forms hydroxyapatite 
crystals. After 2  d  of treatment, the progressive develop- 
Figure 1.  Phenotypic conversion of C1  cells into osteocyte-, chondrocyte-, and adipocyte-like cells. Toluidine blue staining on nodule 
sections (A) control at 50 d  of culture;  (B) [3-GP and AA-treated nodules at 20 d  of culture showing matrix mineralization stained by 
Von Kossa; (C) DEX-treated nodules at 50 d  of culture showing chondrocytes contained in lacuna separated by an extracellular matrix; 
(D) Fat droplets stained with oil red O: monolayer culture of C1 cells after 20 d  of treatment with DEX and insulin. Bars: (A, B, and C) 
10 ~m; (D) 50 ixm. 
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manner in almost 100% of the C1 aggregates (Kellermann 
et al., 1990; Chentoufi et al., 1993; Poliard et al., 1993). 
In the presence of DEX (10-6M), after a minimum of 25 d, 
C1 aggregates show foci of chondroblast-like cells with a 
cuboidal  morphology  and  a  typical  metachromatic  and 
perilacunar staining with toluidine  blue  (Fig.  1 C).  More 
than 80%  of the  C1  aggregates acquires foci of chondro- 
blast-like cells heterogeneous in size. As in vivo maturat- 
ing chondrocytes, cells reside in lacunae surrounded by an 
extracellular matrix of thin type II Col fibrils and electron- 
dense small condensations of putative proteoglycans (Fig. 
2). After 3 mo of exposure to DEX, the lacunae progres- 
sively become larger and the chondrocytes undergo termi- 
nal  differentiation  to  produce  hypertrophic  cells  (not 
shown). 
When monolayers of confluent C1 cells are exposed to 
both DEX (10-7M) and insulin (10-6M), two known posi- 
tive regulators  of adipogenic differentiation  (Kodama et 
al., 1982; Ringold et al., 1986; Ailhaud et al., 1992), the ad- 
ipocyte differentiation occurs in a reproducible and almost 
synchronous manner. After 17 d, more than 80% of the C1 
cells are positively stained by oil Red O  which specifically 
reveals the presence of triglycerides (Fig. 1 D). 
Noteworthily, in the absence of inducers, the clonal C1 
cells maintain a  stable phenotype for months  (Fig.  1 A). 
Matrix formation, Ca  ++  accumulation and mineralization 
are  never observed within  untreated  C1  nodules  (Chen- 
toufi et al., 1993).  After 120 d  of culture less than 5%  of 
the  control  aggregates  initiate  chondrogenic  differentia- 
tion by secreting a  weak type II Col extracellular matrix 
deprived  of  proteoglycan  (not  shown).  Finally,  in  long 
term monolayer cultures (over 3 mo) C1 cells never spon- 
taneously differentiate into fat-containing cells. 
These observations suggest that the clone C1 behaves as 
a tripotential mesodermal precursor whose choice of fate 
depends on both the spatial organization of the cells and 
the nature of the induction. To further strengthen this con- 
clusion, the patterns of gene expression underlying these 
alternative phenotypic conversions were examined. 
Chondrogenic Differentiation 
Cartilage Specific Gene Expression Occurs during the Dif- 
Figure 2. Electron micrograph of C1 chondrocyte performed on a nodule section after 60 d of DEX treatment. The cell resides in a la- 
cuna, cellular processes appear along the chondrocyte membrane. (inset)  The extracellular matrix consist of a network of thin type II 
collagen fibrils, banded fibrils, and small electron dense condensations of proteoglycans. Bar, 1 ~m. 
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drocytes. Steady-state levels of transcripts encoding type I, 
II, IX, X, or XI Col, large proteoglycan core protein and 
link protein were evaluated by Northern blot analysis, dur- 
ing C1 chondrogenic differentiation. 
At day 0, type I, II, XI Col mRNAs are already detect- 
able,  independent  of the  presence  or  absence  of DEX 
(Fig. 3). Upon addition of 10-6M DEX, the steady-state 
levels  of these  transcripts  considerably change  over the 
following 85-d  period  (Fig.  3).  In  untreated  aggregates, 
these mRNAs do not significantly vary (not shown). 
Type I  Col mRNA, the major constituent of bone ma- 
trix, is known to be expressed in chondroprogenitors cells 
(Kosher et al., 1986; Tacchetti et al., 1987). Around day 25, 
a time which coincides with the development of cartilage 
foci,  type  I  Col  mRNA  level  declines.  At  day  50  the 
amount of type I  Col mRNA has dramatically decreased 
Figure 3.  Kinetics of gene expression during chondrogenic differ- 
entiation analyzed by Northern blotting: type I, II, XI, X, and IX 
Col; Aggrecan; Link protein; Osteocalcin; histone H4; GAPDH. 
Total RNA were extracted from 3D aggregates after 0, 10, 25, 50, 
and 85 d of DEX treatment or after 10 d of treatment with DEX 
and retinoic acid (10"). 
(Fig. 3). At day 85 however it increases again. This coin- 
cides with the maturation of the C1 cells to fully differenti- 
ated hypertrophic cells. The steady-state level of osteocal- 
cin  mRNAs  parallels  those  of  type  I  Col  during  the 
kinetics (Fig. 3). 
The level of mRNA encoding type If Col, a major com- 
ponent of cartilage matrix, increases until day 25,  before 
the first morphologic differentiation of the cells (Fig. 3). 
At later times, it decreases continuously until the end of 
the culture. In a similar way, the level of type XI Col tran- 
scripts, encoding one of the minor cartilagenous collagens, 
peaks on day 25 and decreases thereafter. 
In contrast to type II and XI Col mRNAs,  transcripts 
encoding other cartilage specific matrix proteins are not 
detected in the early stage of C1 differentiation before the 
onset of visible chondrogenesis. Expression of all moni- 
tored cartilage-specific genes is detected at day 25 (Fig. 3). 
Transcripts  encoding  type  IX  and  also  type  X  Col,  a 
marker of the fully differentiated chondrocytes, are  still 
expressed at day 50 and, at low level, at day 85. 
A  major structural component of the extracellular ma- 
trix  of cartilage  is  aggrecan,  a  proteoglycan capable  to 
form aggregates with hyaluronic acid (Doege et al., 1987). 
The interaction of aggrecan with hyaluronic acid is stabi- 
lized by the link protein. The mRNA  encoding the pro- 
teoglycan core protein, as well as the two mRNAs of the 
link protein (Rhodes et al., 1988) are expressed mostly at 
day 25. These latter transcripts are still measurable at day 
50  and  become undetectable  thereafter  (Fig.  3).  There- 
fore, in parallel to the progression of the C1  aggregates 
through chondrogenic differentiation, the steady-state lev- 
els  of the  mRNA  encoding extracellular matrix compo- 
nents undergo large variation. 
Interestingly, if retinoic acid (5  x  10-TM) is  added in 
combination with DEX to C1  nodules, chondrogenic dif- 
ferentiation does not occur. Type II Col mRNA rapidly 
declines and is almost undetectable as early as day 10 (Fig. 
3). This is  consistent with the  observations that  retinoic 
acid interferes with cartilage differentiation in vivo (Sol- 
ursh, 1989) and in skeletal cells (Horton et al., 1987; Bern- 
ier and Goltzman, 1993). 
Type I and H Collagen mRNAs Acquire Distinct Cellular 
Distributions before the Onset of Visible Chondrogenic Dif- 
ferentiation  of C1 Cell. In vivo, the initial stages  of chon- 
drogenesis include a switch in Col synthesis, from type I to 
type II Col (Kosher et al., 1986; Tacchetti et al., 1987). To 
observe this switch at the single-cell level, an in situ hy- 
bridization analysis was performed. 
At day 0, before the addition of DEX, type I and If Col 
transcripts are present in the majority of the cells, suggest- 
ing that C1 precursor cells coexpress the two types of col- 
lagen transcripts (as in Fig. 4 A). At day 17, before the on- 
set of visible chondrogenesis, type I Col transcripts are still 
uniformly distributed over the aggregates in a way similar 
to that observed at day 0 (Fig. 4 A). Regarding type II Col, 
an increase in the silver grain density becomes visible over 
the condensed cells area (Fig. 4 B). These cells may corre- 
spond  to  the  condensation  of presumptive  prechondro- 
genic cells. This observation is in agreement with the over- 
all enhancement of type II Col mRNAs  as measured by 
Northern blot (25 d)  (Fig. 3). At day 50,  the type I  Col 
mRNA signal has become almost undetectable. The hy- 
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differentiated cartilage loci (not shown). 
Immunochemical  Localization of type I and H Collagens 
and of the Aggrecan Protein during Chondrogenic Differen- 
tiation of C1 Cells. To establish relationships between the 
time course of gene expression and that of cartilage matrix 
formation,  we  have  followed  the  cellular  localization  of 
three important matrix proteins: type I and II Col and ag- 
grecan. 
As already pointed out for osteogenic differentiation, in 
exponentially growing C1 cells, none of the differentiation 
markers are expressed (Fig. 5). As soon as cells establish 
contacts, type I and II Col become detectable with specific 
antibodies (Poliard et al., 1993, and Fig. 6 A, respectively). 
The signal is weak but significant when compared to con- 
trol experiments performed without primary antibody or 
with nonimmune serum. The synthesis of the two Col ob- 
served in aggregate sections (Fig. 6 A; Poliard et al.,  1993) 
as well as in confluent cells (for type I  Col; Poliard et al., 
1993)  does not require addition of any inducer. After the 
cells have established contacts and the  two Col have be- 
come detectable within most of the cells, the type of extra- 
cellular matrix produced by the C1 cells critically depends 
on the nature of inducers. 
Upon commitment by the addition of AA and [3GP to- 
wards osteogenic differentiation,  type I  Col is assembled 
and forms an extracellular matrix as early as day 2.  It is 
profusely secreted by day 5, whereas at the same time type 
II collagen is no longer detectable. The localization of os- 
Figure 4. Autoradiographs of serial sections of aggregates treated 
by DEX for 17 d processed for in situ hybridization.  (A) Type I 
Col  transcripts  appear uniformly  distributed.  (B) Type II Col 
transcripts  appear overexpressed over the condensed  cell area. 
Bar, 30 Ixm. 
Figure 5.  Northern blot analysis of gene expression in untreated 
C1 cells before or after establishment  of cell contacts. Total RNA 
or Poly A + RNA for Id and M-Twist were extracted from expo- 
nential  (Ex), confluent  (Cf),  or  untreated  control  aggregates 
(3D): Type I Col; Type II Col; LPL; A2COL6;  M-Twist; Id and 
13-Actin. 
teocalcin superimposes on that of type I Col. (Chentoufi et 
al., 1993; Poliard et al., 1993).  Upon addition of DEX, co- 
expression of type I and II Col are maintained until day 25 
(Fig. 6 B). Between day 30-40, type I Col vanishes in 90% 
of the nodules, whereas type II Col and proteoglycan get 
settled into an extracellular network (respectively, Fig. 6, 
C-D and 6, E-F). After day 50, type II Col and proteogly- 
can matrix systematically delineates cartilage foci of heter- 
ogenous sizes recognizable  in  more than  80%  of the  C1 
nodules.  At all these times, osteocalcin is never detected 
by immunofluorescence analysis (not shown). 
Interestingly, at day 85, while chondrocytes undergo ter- 
minal differentiation,  type  I  Col  is  synthesized  de  novo, 
being  accumulated  in  the  extracellular  space  in  almost 
50% of the aggregates (not shown). This observation is in 
agreement with the significant reappearance of type I Col 
mRNAs (Fig. 3). 
Adipocyte Differentiation 
Changes in Gene Expression during Adipocyte Differentiation 




























































































































































































































































































































































































































































































































































































































































































































































 of C1 Cells. Northern blots were performed to character- 
ize expression of adipocyte-specific genes during commit- 
ment of C1 mesodermal cells towards adipocyte differenti- 
ation.  LPL  and  A2COL6  transcripts,  two  known  early 
markers of adipose cell differentiation, are not detectable 
as long as C1  cells have not established contacts (Fig. 5). 
At  confluency or  in  3D  aggregates,  A2COL6  and  LPL 
mRNAs are expressed, independent of the presence or ab- 
sence of any inducer (Fig. 5). The level of these transcripts 
remains similar during adipocyte differentiation (Fig. 7). 
After day 14, lipid droplets appear in C1  cells and the 
transcripts encoding the ALPB or the GPDH start to ac- 
cumulate (Fig. 7). If one of the inducers (insulin or DEX) 
is missing, ALBP and GPDH transcripts are not detected. 
This behavior is in agreement with the fact that adipocytes 
are never observed without inducers or treatment by insu- 
lin alone. Upon long term exposure (50 d) to DEX alone, 
less than 20% of CI cells show lipid droplets. As expected, 
Figure 7. Kinetics of gene expression during adipogenic differen- 
tiation  analyzed by Northern blotting, a2 chain of type VI col- 
lagen (A2Co16);  lipoprotein lipase (LPL); adipocyte lipid-binding 
protein  (ALBP);  glycerol-3-phosphate dehydrogenase  (GPDH); 
type II Col; type I Col; Osteocalcin; Histone H4; [3 actin. Total 
RNA were extracted from cells treated for 0, 4, 8, 11, 14, 17, or 
20 d by DEX and insulin or extracted from C1 cells treated for 
20 d with DEX(20*) or insulin alone (20**). 
the level of actin mRNA decreases concomitantly with ad- 
ipose cell differentiation (Cornelius et al., 1994). 
Noteworthily, the steady-state levels of type I and II Col 
and  osteocalcin transcripts  decrease  concomitantly with 
the  acquisition of late markers  of adipogenesis  (day 17) 
(Fig. 7). At the same time, the cells stop dividing and more 
than 80% become irreversibly engaged towards the termi- 
nal differentiation. The absence of cartilage or bone ma- 
trix  formation  during  adipogenesis  is  further  demon- 
strated,  in  long  term  cultures  (50  days),  by the  lack  of 
staining with alcian blue or Von Kossa after addition of 
[3GP (not shown). 
Lipolytic Property of C1 Adipocytes. One of the most impor- 
tant characteristics of adipocytes is their ability to respond 
to 13-adrenergic agonists by the hydrolysis of stored triglyc- 
erides.  To analyze the  lipolytic properties  of C1  adipo- 
cytes, we prelabeled the endogenous triglycerides on the 
fatty acid moiety using  [14C]acetate.  The addition of iso- 
proterenol results in a strong fatty acid release which re- 
mains nearly linear for at least 2 h (Fig. 8 A). The level of 
fatty acid release at 2 h  varies with the concentration of 
isoproterenol (Fig.  8 B). A  maximum 10-fold increase is 
obtained  with  the  addition  of 1  nM  isoproterenol,  The 
half-maximal  effective  concentration  is  ~-60  pM,  thus 
showing the high sensitivity of C1 adipocytes to this agent. 
The 13-adrenergic antagonist, propranolol (1 p,M) partially 
prevents  the  isoproterenol-induced  lipolysis  (Fig.  8  B). 
These results suggest that 13-adrenergic receptors mediate 
the lipolytic action of isoproterenol. Finally, insulin exerts 
an antilipolytic effect on differentiated C1 cells (Fig. 8 B). 
Thus,  these  cells clearly express  the  lipolytic properties 
characteristic of adipocytes. 
Transition  to Terminal  Chondrogenic  or Adipogenic  Dif- 
ferentiation Is Accompanied by the Loss of the Proliferative 
Potential of Immortalized C1 Cells. While immortalized by 
SV40T antigen under the control of adenovirus E1A pro- 
moter, the clonal C1 cells have retained the capacity to re- 
spond to signals and to convert into homogenous differen- 
tiated progeny along mutually exclusive pathways. To gain 
some insight in the balance between proliferation and dif- 
ferentiation  of  these  cells,  their  proliferative  state  was 
evaluated using histone H4 gene expression as an index of 
DNA replication. 
C1 cells continue to proliferate during the time course of 
the three differentiation programs. The level of H4 tran- 
scripts drops sharply only: (a) at day 85 of the chondro- 
genic  differentiation,  when  large  loci  of  hypertrophic 
chondrocytes have expanded within the C1  nodules (Fig. 
3) (b) at day 17 of the adipogenic differentiation, when de- 
tectable lipid droplets accumulate in the cytoplasm (Fig. 
7). In the case of the osteogenic differentiation, [3H]thymi- 
dine  incorporation experiments had  already indicated  a 
block  in  the  proliferation of the  osteocyte-like cells,  as 
soon  as  they  are  embedded  within  the  calcified matrix 
(Chentoufi et al.,  1993).  Therefore, while maintaining C1 
cells in their proliferative state along each differentiation 
program, the expression of SV40 T  antigen does not pre- 
vent an arrest of the cell cycle when the terminal stages of 
differentiation are reached. 
Discussion 
This study presents the teratocarcinoma-derived C1 clone 
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Figure 8. Lipolytic response  of differentiated C1 cells to isopro- 
terenol. (A) Time course of isoproterenol action [] basal; •  iso- 
proterenol 10  -7 M. (B) Effect of isoproterenol concentration.  Li- 
polysis was carried out for 1 h with increasing concentration of 
isoproterenol in the absence  •  or in the presence  (3 of 10-6M 
propranolol; •  cells were preincubated for 30 min with 10-VM in- 
sulin, and then isoproterenol 10  l°M was added for 1 h. Fatty 
acid-linked  radioactivity  present in the medium  at time 0 was 
substracted from each value. Values represent the mean -+ SEM 
data obtained from six plates in two independent experiments. 
as a mesodermal stem cell (a) having the capacity of self 
renewal by maintaining  a  stable undifferentiated pheno- 
type under long term standard culture conditions, and (b) 
giving rise upon induction to a progeny which can be com- 
mitted to three mesodermal fates: bone, cartilage, or adi- 
pocyte. C1 cells are driven towards terminal stages of each 
alternate pathway with high frequency, depending only on 
two sequential types of epigenetic signals. The first signal 
is mediated by the establishment of contacts between the 
cells  and  the  second by the  addition  of appropriate  in- 
ducers. 
The Chondrogen& Differentiation of C1 Cells Is 
Similar to In Vivo Chondrogenesis 
The  factors  regulating  chondrogenic  differentiation  are 
still largely unknown, partly because of the lack of induc- 
ible model systems. Moreover, in vitro, chondrocytes rap- 
idly lose their phenotypic markers such as type II Col and 
cartilage proteoglycan (Mayne et al.,  1976; yon der Mark 
et al., 1977). Immortalized clones retaining constitutive type 
II  Col  expression  have  been  isolated  from rat  calvaria 
(Grigoriadis et al.,  1989), c-los-induced  cartilage tumors 
of chimeric mice (Wang et al.,  1993)  or from embryonic 
mouse limb chondrocytes infected by a recombinant retro- 
virus transducing the SV40 T antigen (Mallein-Guerin and 
Olsen, 1993). The C1 clone corresponds to an earlier state 
of commitment. Its potential for proliferation and the ho- 
mogeneity of its phenotypic conversion offer, therefore, 
the opportunity to follow the temporal sequence of events 
underlying in vitro chondrogenesis, from the C1 progeni- 
tor cell stage to a fully differentiated culture. 
The commitment of C1  to the  chondrogenic pathway 
appears to be controlled at two levels: (a) cell-cell interac- 
tions in 3D aggregates provide the permissive condensed 
environment for cartilage differentiation. Transcription of 
type I, II, XI Col are triggered at this stage, although the 
matrix has not yet been formed; (b) the addition of 10-6M 
DEX leads to time-dependent changes in gene expression 
during the development and maturation of cartilage foci to 
the hypertrophic stage. At day 40, more than 80% of the 
C1 aggregates have developed a profuse extracellular ma- 
trix of type II Col and proteoglycan. The effects of gluco- 
corticoids on chondrocyte progenitors vary depending on 
the culture systems (Kato et al., 1985; Takano et al., 1985). 
As observed for the calvaria RCJ3.I cell line (Grigoriadis 
et al.,  1988), C1  chondrocytes appear in the presence of 
DEX  (10-6M)  and  the  frequency of differentiation de- 
creases with a  lowering of the DEX concentration (fre- 
quency <10% at 10-SM). DEX is likely to act as a single 
cell  signaling  molecule.  Interferences with  autocrine  or 
growth  factors  such  as  proteins  members  of the  TGF[3 
family  (Adams  and  Watts,  1993;  Tschan  et  al.,  1993; 
Reddi, 1994) or undefined components of the media (1% 
FCS) may also occur. 
The pattern of gene expression in chondrocytes of mes- 
ectodermal (neural crest) or diverse mesodermal lineages 
(somites, limb bud, notochord, etc.) has been only partly 
followed  during  embryogenesis.  Nevertheless,  the  few 
available in vivo observations indicate  that cartilages of 
different developmental fates  have  features in  common 
with  those  observed  during  the  kinetics  of C1  in  vitro 
chondrogenesis. At the earliest stages, the mesenchymal 
precursors condense and produce type I and a basal level 
of  type  II  Col.  In  addition,  they  express  type  XI  Col 
mRNA  (Cheah  et al.,  1991; Nah et al.,  1992).  After the 
stage of precartilagenous condensation, cartilage cells be- 
come detectable histologically and a switch occurs in Col 
synthesis  from  type  I  to  type  II.  Type  I  Col  synthesis 
decreases, while the levels type II and XI Col transcripts 
increase (Castagnola et al., 1988; Strauss et al., 1990). After- 
ward, proliferating chondrocytes express all the cartilage- 
specific marker transcripts, namely aggrecan, link protein, 
type II, IX, and XI Col (Kosher et al., 1986; Bornstein and 
Sage,  1989).  As  differentiation continues towards  chon- 
drocyte hypertrophy, type X Col becomes synthesized (Tac- 
chetti et al., 1987; Bruckner et al., 1989). In the case of C1, 
the transcripts of all the genes encoding specific cartilage 
matrix  components  (van  der  Rest  et  al.,  1993)  are  ex- 
pressed at  the  stage  of patent  chondrogenesis (day 25). 
This behavior parallels  the  in vivo situation  (Stirpe and 
Goetinck, 1989; Wood et al.,  1991; Cheah et al., 1991; Ng 
et al., 1993). Type II Col and aggrecan mRNAs are present 
(day 25) before the corresponding proteins become pro- 
fusely settled within the C1 extracellular matrix (day 30- 
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C1  cells, the steady-state level of the osteocalcin mRNA 
sharply drops at the time of overt expression of the carti- 
lage phenotype (day 50). The de novo synthesis of type I 
Col by resting C1  chondrocytes (at day 85)  are puzzling 
but have already been reported (Strauss et al., 1990; Des- 
calzi-Cancedda et al., 1992).  It might contribute to the po- 
tential of hypertrophic chondrocytes to prepare cartilage 
before ossification. Beyond the role of DEX, the develop- 
ment of the chondrocyte phenotype may depend also on: 
(a)  the  interactions  of the  cells with matrix components 
and (b) autocrine factors, hormones or growth factors con- 
centrated  within  the  matrix  (Adams  and  Watt,  1993; 
Tschan et al., 1993; Reddi, 1994).  Such agents added to the 
culture medium could improve the response of the C1 cells 
to DEX and reduce the time course of their differentiation. 
In spite of the presence of Dex (10-6M or either 10  7M), 
islands  of  adipocytes  were  never  observed  during  the 
chondrogenic  differentiation  unless  AA  was  added.  As 
observed for other murine embryonic cell lines (Mallein- 
Gerin et al., 1993;  Atsumi et al., 1990)  and for human or 
bovine  chondrocytes  (Kirsh  et  al.,  1992;  Daniel  et  al., 
1984),  AA does not seem absolutely required for the for- 
mation of the cartilagenous matrix (Fig. 2 and 6, D and F). 
When AA (50 ixg/ml) is added to Dex-treated aggregates, 
the nodules becomes larger and more adherent but the ki- 
netics  of chondrogenic  differentiation is not significantly 
reduced  and  clusters  of adipocytes  reproducibly  appear 
within 25  d  at the periphery of the spreading aggregates. 
This effect of AA, as a potent activator of adipose cell dif- 
ferentiation  was  previously observed  (Ono  et  al.,  1990; 
Kawada et al., 1990). 
The Adipogenic Differentiation of CI Cells Resembles 
That of Preadipocyte Cell Lines 
The C1 progenitor cells can also be committed to the adi- 
pogenic program. At  confluency,  addition  of both DEX 
(10  7M)  and insulin (10-6M)  are strictly required  to trig- 
ger the conversion of more than 80% of the C1 precursors 
to adipocytes. Since the C1 cell line has also the capacity to 
produce  bone  and  cartilage, it must represent  an earlier 
stage of developmental commitment than that of classical 
preadipocyte cell lines which  all are  unequivocally com- 
mitted to adipogenesis (for review see Ailhaud, 1992). 
Early and late events characterizing the differentiation 
in various  adipogenic cell lines  can be recognized in  C1 
cells.  The mRNAs encoding the  early markers LPL and 
A2COL6  become  detectable  as  soon  as  the  ceils  reach 
confluency. The GPDH and ALBP transcripts, which mark 
terminal  differentiation,  appear  at  the  time  when  lipid 
droplets arise from triacyl glycerol accumulation. Interest- 
ingly, C1 cells express high levels of type I  and II Col as 
well as osteocalcin mRNAs until the onset of the late stage 
of adipogenesis. Since these markers are those of bone and 
cartilage, the question may be asked whether reversion to- 
wards an osteogenie or chondrogenic direction can be ob- 
tained during early adipogenesis. This is of obvious inter- 
est for particular  skeletal connective tissue  pathology in 
which bone loss is associated with an increase of adipose 
tissue (Meunier et al., 1971). 
Concluding Remarks 
During embryogenesis, osteogenic and chondrogenic stem 
cells may arise from the  sclerotomal cells of the  somitic 
mesoderm, the somitomeres of the hindbrain  or the me- 
sectodermal cells of the neural crest. They are believed to 
derive from a common embryonic progenitor cell (Thoro- 
good, 1988; Couly et al., 1992; Recker, 1992) whereas the de- 
velopmental origin of fat cells remains unclear.  Primitive 
fat cell clusters are formed at the end of the human gesta- 
tion period, whereas, in rodent, white adipose tissue can- 
not  be  detected  during  embryonic life  or  even  at  birth 
(Ailhaud et al., 1992).  Nevertheless, it is generally agreed 
that adipose precursors arise from multipotential embry- 
onic stem cells determined to become either adipoblasts or 
other types of mesodermal cells. In the adult, there is also 
evidence that adipogenic or osteogenic cells might derive 
from  a  common  stromal  stem  cell  of the  bone  marrow 
(Fridenstein,  1976;  Beresford,  1989;  Bennett  et al.,  1991; 
Berry et al., 1992).  It also confirms the close ontogenic re- 
lationship occurring between various members of the skel- 
etal connective tissue family. 
Fig. 9 summarizes our current views about the develop- 
mental stages of the C1 mesodermal cell line. The clonal 
C1  progenitor is tripotent capable of giving rise to either 
osteocytes,  chondrocytes,  or  adipocytes.  In  sparse  cul- 
tures, it exhibits the properties of a  true progenitor cell; 
(a)  It  possesses  an  intrinsic  developmental  program  re- 
stricted to mesodermal lineage; (b) It has the ability of cell 
renewal; (c) It displays a stable immature phenotype asso- 
ciated with a lack of significant expression (Northern blot 
limited detection) of any differentiation markers. In addi- 
tion, it expresses a series of genes encoding transcription 
factors that are potential regulators of mesodermal stem 
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bHLH  gene  family  known to  be  expressed  in  the  early 
sclerotome and limb bud (Evans and O'Brien, 1993). 
The establishment of cellular interactions has a  critical 
role in C1 osteogenic differentiation (Poliard et al., 1993) 
and in the triggering of the transcription of early genes re- 
lated to cartilage (type I, II, XI Col) (Figs. 3 and 5) or adi- 
pocyte  (LPL,  A2COL6)  differentiation  (Figs.  7  and  5). 
Our  results  suggest  that  the  spatial  organization  of  C1 
cells, 3D or monolayer cultures is important to provide a 
permissive  environment for differentiation  to take place. 
The C1 progenitor cells become competent to respond to 
directive  signals  eliciting  alternative  fates,  provided  they 
have established appropriate contacts. The competent C1 
cells are still only "determined," since they do not differ- 
entiate  spontaneously.  In vivo, interactions  between  ho- 
mologous cells  appear to play a  fundamental role in the 
initiation of mesodermal programs and the control of gene 
expression (Gurdon, 1988).  Indeed, prechondrogenic and 
preosteogenic condensations are a prerequisite  for skele- 
tal formation (Daniels and Solursh, 1991) and primitive fat 
cluster formation preceeds the development of adipose tis- 
sue (Ailhaud et al., 1992).  Little is still known of the pre- 
cise role of cadherins, integrins, or growth factor receptors 
in the commitment of mesodermal precursor cells (Takhe- 
ichi,  1988)  but  these  molecules  certainly  appear  as  first 
choice candidates in the mediation of these interactions. In 
particular, members  of the TGFI3  superfamily of growth 
factors such as activin, TGF[3, and BMPs have been shown 
to be important in the processes of condensation and dif- 
ferentiation of cartilage, bone, and fat cells  (Jiang et al., 
1993; Leonard et al., 1991; Chen et al., 1991; Ahrens et al., 
1993;  Rosen et al.,  1994).  In this context,  the in vitro C1 
clonal system will be  helpful  for deciphering  the  role  of 
these molecules in mesodermal differentiation. 
Although  systematic  experiments  for each  differentia- 
tion marker have not yet been performed, the results from 
Northern blot, in situ, and immunocytochemical analyses 
support  the  idea  that  the  great  majority  of the  C1  cells 
having reached  the  competent  state,  coexpress  the  early 
genes of the three differentiation programs. 
Finally,  the  addition  of appropriate  inducers  is strictly 
required  to turn on one or the other differentiation pro- 
gram.  Each  inducer  acts  as  an  instructive  signal  since  it 
elicits a temporal regulation of gene expression capable to 
drive cells to the differentiated endstage. As compared to 
the  other  mesoblastic  cell  lines  and  in  particular  to  the 
C3H10T1/2 cell line, the C1 cells are able to univocally dif- 
ferentiate towards a single phenotype either chondrocyte, 
osteocyte, or adipocyte. These phenotypic conversions oc- 
cur in each case with a very high frequency and have fea- 
tures close to those of the corresponding in vivo differenti- 
ation processes.  Beyond  the fact that  C1  cells  provide  a 
valuable tool for the study of in vitro chondrogenic differ- 
entiation, the C1 clone also appears as a promising system 
for deciphering the molecular basis of mesoblast ontogeny. 
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